Healthcare ❯ Pharmaceutical Industry ❯ Drug Development

Clinical Trials

Innovative Therapies Regulatory Affairs Regulatory Approval Phase III Trials Market Launch

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

Robust double-digit profit growth spurred a reassessment of a U.S. primary listing to strengthen its presence in the world’s largest biopharmaceutical market.